{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:04:21Z","timestamp":1789517061730,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaccao.2026.07.007","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T19:31:50Z","timestamp":1787081510000},"page":"415-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Divergent Effects of GnRH Agonist and GnRH Antagonist Treatment on Platelet Activity and Transcriptome"],"prefix":"10.1016","volume":"8","author":[{"given":"Antonia","family":"Beitzen-Heineke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5948-997X","authenticated-orcid":false,"given":"Matthew","family":"Siskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshini","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn C.","family":"Hafertepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minas","family":"Economides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2026.07.007_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jaccao.2024.09.012","article-title":"Cardiovascular risk in prostate cancer: JACC: cardiooncology state-of-the-art review","volume":"6","author":"Leong","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib2","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1200\/JCO.2010.29.1567","article-title":"Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the population-based PCBaSe Sweden","volume":"28","author":"Van Hemelrijck","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib3","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1161\/ATVBAHA.119.313046","article-title":"Cardiovascular effects of androgen deprivation therapy in prostate cancer: contemporary meta-analyses","volume":"40","author":"Hu","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41585-025-01002-0","article-title":"Assessing the effects of prostate cancer therapies on cardiovascular health","author":"Tisseverasinghe","year":"2025","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib5","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2004325","article-title":"Oral relugolix for androgen-deprivation therapy in advanced prostate cancer","volume":"382","author":"Shore","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccao.2026.07.007_bib6","first-page":"87","article-title":"Thrombo-inflammation linking androgen suppression with cardiovascular risk in patients with prostate cancer","volume":"10","author":"Beitzen-Heineke","year":"2024","journal-title":"Cardiooncology"},{"key":"10.1016\/j.jaccao.2026.07.007_bib7","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1210\/en.2010-0663","article-title":"Androgen receptor-dependent and independent atheroprotection by testosterone in male mice","volume":"151","author":"Bourghardt","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaccao.2026.07.007_bib8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/ATVBAHA.123.319426","article-title":"FSH is responsible for androgen deprivation therapy-associated atherosclerosis in mice by exaggerating endothelial inflammation and Monocyte adhesion","volume":"44","author":"Wang","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib9","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccao.2026.07.007_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0481","article-title":"Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis","volume":"11","author":"Barrett","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaccao.2026.07.007_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.960398","article-title":"Platelet-monocyte aggregates: molecular mediators of thromboinflammation","volume":"10","author":"Rolling","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jaccao.2026.07.007_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2018.12.029","article-title":"Circulating monocyte-platelet aggregates are a robust marker of platelet activity in cardiovascular disease","volume":"282","author":"Allen","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaccao.2026.07.007_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jacl.2024.11.008","article-title":"Variation in lipoprotein(a) response to potent lipid lowering: the role of apolipoprotein (a) isoform size","volume":"19","author":"Akinlonu","year":"2025","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.195824","article-title":"A platelet transcriptomic signature of thromboinflammation predicts cardiovascular risk","volume":"10","author":"Beitzen-Heineke","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaccao.2026.07.007_bib15","series-title":"Seq-N-Slide. Version 24.08 ed","author":"Dolgalev","year":"2024"},{"key":"10.1016\/j.jaccao.2026.07.007_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaccao.2026.07.007_bib17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaccao.2026.07.007_bib18","series-title":"Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data Version 0.11.7","author":"Andrews","year":"2018"},{"key":"10.1016\/j.jaccao.2026.07.007_bib19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1055\/s-0040-1721386","article-title":"Immature platelets and risk of cardiovascular events among patients with ischemic heart disease: a systematic review","volume":"121","author":"Faber","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaccao.2026.07.007_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jacc.2017.10.072","article-title":"Platelet-Derived MRP-14 induces Monocyte activation in patients with symptomatic peripheral artery disease","volume":"71","author":"Dann","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx0268","article-title":"Platelets induce endothelial cell mitochondrial dysfunction in myocardial infarction","volume":"11","author":"Sun","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.jaccao.2026.07.007_bib22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1186\/s12864-016-3059-6","article-title":"RNAseq analysis of heart tissue from mice treated with atenolol and isoproterenol reveals a reciprocal transcriptional response","volume":"17","author":"Prunotto","year":"2016","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jaccao.2026.07.007_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2006.09.005","article-title":"Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators","volume":"10","author":"Hieronymus","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jaccao.2026.07.007_bib24","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1038\/s41598-023-29450-x","article-title":"Prostate cancer cell-platelet bidirectional signaling promotes calcium mobilization, invasion and apoptotic resistance via distinct receptor-ligand pairs","volume":"13","author":"Garofano","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaccao.2026.07.007_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1160\/TH03-11-0679","article-title":"Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma","volume":"92","author":"Caine","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaccao.2026.07.007_bib26","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/CIRCRESAHA.122.321861","article-title":"Mechanism of tumor-platelet communications in cancer","volume":"132","author":"Dudiki","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.jaccao.2026.07.007_bib27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaccao.2024.10.010","article-title":"Shared mechanisms in cancer and cardiovascular disease: S100A8\/9 and the NLRP3 inflammasome: JACC: cardiooncology state-of-the-art review","volume":"7","author":"Van Linthout","year":"2025","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib28","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/jth.14466","article-title":"The formyl peptide fMLF primes platelet activation and augments thrombus formation","volume":"17","author":"Salamah","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaccao.2026.07.007_bib29","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1182\/blood.2024025593","article-title":"N-homocysteinylation of \u03b2-arrestins biases GPCR signaling and promotes platelet activation","volume":"145","author":"Zhang","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2026.07.007_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910656","article-title":"Opposing roles of GSK3\u03b1 and GSK3\u03b2 phosphorylation in platelet function and thrombosis","volume":"22","author":"Moore","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.jaccao.2026.07.007_bib31","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/jth.14197","article-title":"TC21\/RRas2 regulates glycoprotein VI-FcR\u03b3-mediated platelet activation and thrombus stability","volume":"16","author":"Janapati","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaccao.2026.07.007_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177924","article-title":"Reprogramming inflammation: mechanisms and therapeutic targeting of eicosanoids and pro-resolving mediators","volume":"1003","author":"Kolawole","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/01.ATV.0000116219.09040.8c","article-title":"Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids","volume":"24","author":"Kr\u00f6tz","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib34","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1161\/ATVBAHA.111.227116","article-title":"Human neutrophil peptides mediate endothelial-monocyte interaction, foam cell formation, and platelet activation","volume":"31","author":"Quinn","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib35","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.it.2023.09.002","article-title":"Mind the GAP: RASA2 and RASA3 GTPase-activating proteins as gatekeepers of T cell activation and adhesion","volume":"44","author":"Johansen","year":"2023","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaccao.2021.09.014","article-title":"How to treat prostate cancer with androgen deprivation and minimize cardiovascular risk","volume":"3","author":"Narayan","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaccao.2022.09.008","article-title":"The burden of uncontrolled cardiovascular risk factors in men with prostate cancer","volume":"5","author":"Klimis","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.07.007_bib38","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3324\/haematol.2022.281726","article-title":"Age- and gender-matched controls needed for platelet-based biomarker studies","volume":"108","author":"Sabrkhany","year":"2023","journal-title":"Haematologica"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326002231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326002231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:45:45Z","timestamp":1789515945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087326002231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666087326002231"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.07.007","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Divergent Effects of GnRH Agonist and GnRH Antagonist Treatment on Platelet Activity and Transcriptome","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}